Recent Finacing
Recent Raise
HBM Alpha Therapeutics, a Cambridge biotech incubated by Harbour BioMed, develops antibody therapeutics for endocrine disorders (CAH, PCOS), with lead candidate in IND‑enabling stage.
Focus Areas
Funding round
